Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McLaughlin

Showing results (641-650 of 808) with videos related to

Pageof 81
Sort By:
Plos Pathogens|December 4, 2009
The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migrationLaura M McLaughlin, Gregory R Govoni, Christiane Gerke, et al.
Assessment|April 24, 2020
The Quality Assurance and Quality Control Protocol for Neuropsychological Data Collection and Curation in the Ontario Neurodegenerative Disease Research Initiative (ONDRI) StudyPaula M McLaughlin, Kelly M Sunderland, Derek Beaton, et al.
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Gene|July 30, 1993
The tyrosine89 residue of yeast FKBP12 is required for rapamycin bindingP L Koser, W K Eng, M J Bossard, et al.
The Biochemical Journal|March 24, 2000
Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cellsR C Gardner, S J Assinder, G Christie, et al.
Journal of Clinical and Experimental Hepatology|April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver DiseaseZobair M Younossi, Michael J Estep, Sean Felix, et al.
Transplantation|December 10, 1997
Characterization of pigs transgenic for human decay-accelerating factorE Cozzi, A W Tucker, G A Langford, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 4, 1999
An epidemiological review of red cell transfusions in cancer chemotherapyJ R Skillings, I Rogers-Melamed, J M Nabholtz, et al.
Cancer Research|May 19, 2001
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapyP M McLaughlin, M C Harmsen, W H Dokter, et al.
Vaccine|February 23, 2025
Effectiveness of BNT162b2 XBB.1.5 vaccine in immunocompetent adults using tokenization in two U.S. statesKathleen M Andersen, Kristen E Allen, Rajeev M Nepal, et al.
Pageof 81

Showing results (641-650 of 808) with videos related to

Sort By:
Pageof 81
Plos Pathogens|December 4, 2009
The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migrationLaura M McLaughlin, Gregory R Govoni, Christiane Gerke, et al.
Assessment|April 24, 2020
The Quality Assurance and Quality Control Protocol for Neuropsychological Data Collection and Curation in the Ontario Neurodegenerative Disease Research Initiative (ONDRI) StudyPaula M McLaughlin, Kelly M Sunderland, Derek Beaton, et al.
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Gene|July 30, 1993
The tyrosine89 residue of yeast FKBP12 is required for rapamycin bindingP L Koser, W K Eng, M J Bossard, et al.
The Biochemical Journal|March 24, 2000
Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cellsR C Gardner, S J Assinder, G Christie, et al.
Journal of Clinical and Experimental Hepatology|April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver DiseaseZobair M Younossi, Michael J Estep, Sean Felix, et al.
Transplantation|December 10, 1997
Characterization of pigs transgenic for human decay-accelerating factorE Cozzi, A W Tucker, G A Langford, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 4, 1999
An epidemiological review of red cell transfusions in cancer chemotherapyJ R Skillings, I Rogers-Melamed, J M Nabholtz, et al.
Cancer Research|May 19, 2001
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapyP M McLaughlin, M C Harmsen, W H Dokter, et al.
Vaccine|February 23, 2025
Effectiveness of BNT162b2 XBB.1.5 vaccine in immunocompetent adults using tokenization in two U.S. statesKathleen M Andersen, Kristen E Allen, Rajeev M Nepal, et al.
Pageof 81